Continuation Study of Lapatinib Monotherapy or Lapatinib in Combination With Other Anti-cancer Agents
Clinical trial NCT00790816 · COMPLETED
Trial details
- NCT number
- NCT00790816
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2008-10-01
- Primary completion
- 2016-08-19
- Enrollment
- 500
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.